We are live on
!
Find out more
ImmunityBio
IBRX
IBRX
262 hedge funds and large institutions have $352M invested in ImmunityBio in 2025 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 91 increasing their positions, 58 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
109% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 23
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
57% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 58
9% more funds holding
Funds holding: 241 → 262 (+21)
7% more capital invested
Capital invested by funds: $328M → $352M (+$24.1M)
1.07% more ownership
Funds ownership: 14.07% → 15.14% (+1.1%)
6% less call options, than puts
Call options by funds: $11.7M | Put options by funds: $12.4M
Holders
262
Holders Change
+21
Holders Change %
+8.71%
% of All Funds
3.44%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
48
Increased
91
Reduced
58
Closed
23
Calls
$11.7M
Puts
$12.4M
Net Calls
-$765K
Net Calls Change
-$452K
Top Buyers
| 1 |
HCM
Heights Capital Management
San Francisco,
California
|
+$16.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15M |
| 3 |
Jane Street
New York
|
+$13.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.53M |
| 5 |
BlackRock
New York
|
+$5.26M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$20.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$18.3M |
| 3 |
Millennium Management
New York
|
-$8.23M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$924K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$888K |